Stockreport

Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF FL is the second most common type of NHL and accounts for approximately 20-30 percent of all global cases If approved, epcoritamab (TEPKINLY ® ) would become the firs [Read more]